Palantir Technologies Pro coverage | TBD · est. | $0.34 vs $0.16 last yr | $1.81B $303.96B mkt cap | Buy 14 Buy · 4 Hold · 2 Sell PT $181.63 | |
Barrick Mining Pro coverage | Pre-Market · est. | $0.85 vs $0.46 last yr | $5.08B $61.40B mkt cap | Strong Buy 8 Buy · 2 Hold · 0 Sell PT $56.50 | |
Crispr Therapeutics AG Pro coverage | TBD · est. | -$1.20 vs -$2.40 last yr | $7.45M $5.15B mkt cap | Buy 9 Buy · 5 Hold · 0 Sell PT $73.85 | |
Hims & Hers Health Pro coverage | TBD · est. | -$0.05 vs $0.17 last yr | $691.65M $7.96B mkt cap | Buy 4 Buy · 9 Hold · 0 Sell PT $30.14 | |
Simon Property Pro coverage | After Close · est. | $1.62 vs $1.70 last yr | $1.60B $70.94B mkt cap | Hold 4 Buy · 13 Hold · 0 Sell PT $217.38 | |
Tonix Pharma | TBD · est. | -$2.64 vs -$3.86 last yr | $7.72M $199.74M mkt cap | Strong Buy 3 Buy · 0 Hold · 0 Sell PT $37.67 | |
Digital Turbine | TBD · est. | $0.14 vs $0.05 last yr | $150.00M $1.27B mkt cap | Buy 2 Buy · 0 Hold · 0 Sell PT $8.75 | |
3D Systems | TBD · est. | -$0.05 vs -$0.07 last yr | $93.76M $501.46M mkt cap | Hold 1 Buy · 3 Hold · 0 Sell PT $5.00 | |
Chegg Pro coverage | TBD · est. | -$0.05 vs $0.10 last yr | $49.52M $95.56M mkt cap | Hold 0 Buy · 1 Hold · 0 Sell | |
Williams Co Pro coverage | TBD · est. | $0.50 vs $0.46 last yr | $2.83B $91.75B mkt cap | Strong Buy 18 Buy · 1 Hold · 0 Sell PT $85.18 | |
Axsome Therapeutics | TBD · est. | -$0.86 vs -$0.97 last yr | $221.62M $12.03B mkt cap | Strong Buy 15 Buy · 1 Hold · 0 Sell PT $266.71 | |
Arcturus Therapeutics | TBD · est. | -$1.00 vs -$0.34 last yr | $3.11M $198.11M mkt cap | Buy 5 Buy · 2 Hold · 0 Sell PT $20.00 | |
TG Therapeutics Pro coverage | TBD · est. | $0.33 vs $0.17 last yr | $228.85M $8.74B mkt cap | Buy 5 Buy · 1 Hold · 1 Sell PT $53.17 | |
Quantum-Si | TBD · est. | -$0.11 vs -$0.16 last yr | $302,000 $192.22M mkt cap | Buy 2 Buy · 1 Hold · 0 Sell PT $2.50 | |
Rocket Pharmaceuticals Pro coverage | TBD · est. | $1.04 vs -$0.62 last yr | $222,000 $426.95M mkt cap | Buy 5 Buy · 2 Hold · 0 Sell PT $11.80 | |
Pennantpark | After Close · est. | $0.27 vs $0.25 last yr | $67.72M $712.38M mkt cap | Strong Buy 3 Buy · 1 Hold · 0 Sell PT $9.88 | |
Sterling Infrastructure Pro coverage | TBD · est. | $5.00 vs $2.69 last yr | $963.25M $20.94B mkt cap | Strong Buy 5 Buy · 0 Hold · 0 Sell PT $928.00 | |
Ocular Therapeutix Pro coverage | TBD · est. | -$0.40 vs -$0.39 last yr | $13.20M $2.23B mkt cap | Strong Buy 9 Buy · 0 Hold · 0 Sell PT $25.50 | |
Turtle Beach | TBD · est. | -$0.31 vs -$0.13 last yr | $60.48M $254.84M mkt cap | Strong Buy 4 Buy · 1 Hold · 0 Sell PT $16.75 | |
Capital Southwest | TBD · est. | $0.57 vs $0.59 last yr | $61.42M $1.48B mkt cap | Buy 1 Buy · 1 Hold · 0 Sell PT $22.75 | |
Alto Ingredients Pro coverage | TBD · est. | $0.08 vs -$0.15 last yr | $231.24M $436.25M mkt cap | Buy 2 Buy · 0 Hold · 0 Sell PT $9.00 | |
Medifast | TBD · est. | -$0.65 vs $0.40 last yr | $72.70M $119.20M mkt cap | No coverage | |
Precigen Pro coverage | TBD · est. | -$0.01 vs -$0.09 last yr | $27.98M $1.90B mkt cap | Buy 2 Buy · 0 Hold · 0 Sell PT $12.50 | |
Atara Biotherapeutics | TBD · est. | -$0.32 vs $0.19 last yr | $550,000 $87.94M mkt cap | Buy 2 Buy · 1 Hold · 0 Sell PT $13.67 | |
W&T Offshore Pro coverage | TBD · est. | $0.01 vs -$0.08 last yr | $154.15M $501.38M mkt cap | Buy 1 Buy · 0 Hold · 0 Sell | |